M. Toubis

Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial

Vassilis Georgoulias, Alexandros Ardavanis, Xanthi Tsiafaki et al. · Journal of Clinical Oncology · 2005 · 163 citations · Full text

Medicine, Oncology, Pharmacology +12

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

George P. Stathopoulos, D. Antoniou, J. Dimitroulis et al. · Annals of Oncology · 2010 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study

Vassilis Georgoulias, Ch. Kouroussis, Athina Agelidou et al. · British Journal of Cancer · 2004 · 59 citations · Full text

Medicine, Oncology, Pharmacology +15

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

Stylianos Kakolyris, E. Papadakis, Xanthi Tsiafaki et al. · Lung Cancer · 2001 · 35 citations

Medicine, Oncology, Pharmacology +12

HLA Antigens and Otosclerosis: A Possible New Genetic Factor

S. Gregoriadis, J. Zervas, E. Varletzidis et al. · Archives of Otolaryngology - Head and Neck Surgery · 1982 · 27 citations

Life Sciences, Genetics, Immunology +17